Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Post by tho411on Nov 04, 2016 9:42am
543 Views
Post# 25424029

THE 02-20 WELL’S PRODUCTION TEST RESULTS

THE 02-20 WELL’S PRODUCTION TEST RESULTSDuring the final 24 hours of a 751 hour production test, the 02-20 well, Blackbird’s third 100% working interest Elmworth Montney well, produced at 6.8 mmcf/d of natural gas and 641 bbls/d of liquid hydrocarbons, for a total of 1,768 boe/d. These excellent results exceeded Blackbird's gas rate and boe/d type curves by 109% and 80% respectively. We believe that the 02-20 well is a top-tier Elmworth Middle Montney well due to the combination of its natural gas test rates and its premier liquids to gas ratio, and to say that we are highly encouraged by the 02-20 results is an understatement.
Bullboard Posts